- FDA advisory panel voted 8-6 to recommend placing BPC-157 and other controversial peptides on a list that would allow broader pharmacy compounding.
- Health Secretary Robert F. Kennedy has expressed support for peptides and vowed to ease restrictions imposed by the Biden administration.
- Restrictions on unapproved peptides were introduced during the Biden administration due to safety concerns.
- Peptides have become popular online, particularly among teens, for unproven claims related to muscle building and skin rejuvenation.
- Health experts have cautioned against the use of peptides, citing a lack of clinical trials and unknown long-term effects.
- The US Anti-Doping Agency states that peptides like BPC-157 have not been extensively studied in humans, raising safety concerns.
- Panel member Elizabeth Rebello voted against BPC-157 due to concerns over efficacy and safety.
An FDA advisory panel has voted to ease restrictions on BPC-157 and other controversial peptides, allowing specialized pharmacies to produce them. The 8-6 vote reflects a shift towards broader access despite warnings from health experts about safety and efficacy.1256
Health Secretary Robert F. Kennedy, a proponent of these substances, aims to reverse restrictions imposed during the Biden administration, which were based on safety concerns. Panel member Elizabeth Rebello expressed her dissent, citing a lack of efficacy data and safety concerns, stating, “I’m concerned we’re responding to a market-induced demand rather than a decision based in solid science.”38
The FDA's decision is not binding, but it may influence future regulations. The panel's composition raised eyebrows, as several members had ties to the peptide industry. David Pope, chief pharmacy officer of Xifin Pharmacy Solutions, supported the decision, saying, “It’s time to put this decision back in the hands of the patient, the physician and the pharmacist.”
Despite the panel's approval, the U.S. Anti-Doping Agency warns that BPC-157 has not been extensively studied in humans, raising concerns about safe dosages and potential long-term effects. The marketplace for these peptides is described as a “wild west,” with unregulated products posing risks of serious harm, including infections and allergic reactions. Peptides are marketed online for various unproven uses, including muscle building and skin rejuvenation, often promoted by influencers on platforms like TikTok.
“The 8-6 vote with one abstention reflected deep divisions, with members from academia voting against and industry-connected members voting in favor. Health experts warn of a 'wild west' of unregulated drugs, citing a lack of human clinical trials and unknown long-term effects.”
The Guardian
